BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3677422)

  • 1. Determination of erythrocyte porphobilinogen deaminase activity using porphobilinogen as substrate.
    Hsiao KJ; Lee FY; Wu SJ; Chang WJ
    Clin Chim Acta; 1987 Sep; 168(2):257-8. PubMed ID: 3677422
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE; Ou CN; Ellefson RD
    Clin Chem; 1980 Jul; 26(8):1182-5. PubMed ID: 7389090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on erythrocyte porphobilinogen deaminase and uroporphyrinogen cosynthetase in porphyria cutanea tarda.
    Blekkenhorst GH; Day RS; Eales L
    Int J Biochem; 1981; 13(8):963-6. PubMed ID: 7053226
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria.
    Sassa S; Kappas A
    N Engl J Med; 1989 Jul; 321(3):192-3. PubMed ID: 2747754
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte porphobilinogen deaminase activity in liver diseases and proliferative diseases of the haemopoietic system and lymph nodes.
    Ostrowski J; Lutyński A; Cianciara J; Martyńska M; Kostrzewska E; Butruk E
    Mater Med Pol; 1987; 19(4):234-7. PubMed ID: 3454831
    [No Abstract]   [Full Text] [Related]  

  • 7. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
    Mustajoki P
    Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA for measuring porphobilinogen deaminase in human erythrocytes.
    Lannfelt L; Wetterberg L; Lilius L; Thunell S; Gellerfors P
    Clin Chim Acta; 1989 Aug; 183(2):227-37. PubMed ID: 2791307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].
    Brodie MJ; Moore MR; Thompson GG; Campbell BC; Goldberg A
    Biochem Soc Trans; 1977; 5(5):1466-8. PubMed ID: 923960
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocyte porphobilinogen deaminase activity in liver disease.
    Ostrowski J
    Gastroenterology; 1987 Apr; 92(4):845-51. PubMed ID: 3556992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroporphyrinogen-I-synthetase activity in red blood cells of lead-exposed workers.
    El-Waseef A
    Acta Med Acad Sci Hung; 1982; 39(1-2):95-100. PubMed ID: 7180366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphobilinogen deaminase and the synthesis of porphyrin isomers in the Dubin-Johnson syndrome.
    Cohen C; Kirsch RE; Moore MR
    S Afr Med J; 1986 Jul; 70(1):36-9. PubMed ID: 3726684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography.
    de Rooij FW; Hamer CM; Wilson JH
    Clin Chim Acta; 1987 Jan; 162(1):61-8. PubMed ID: 3802547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrin biosynthesis and enzymatic studies in erythrocytes from normals and porphyric humans.
    Parera VE; Stella AM; Wider de Xifra EA; Fukuda H; Batlle AM
    Int J Biochem; 1980; 12(5-6):947-53. PubMed ID: 7450154
    [No Abstract]   [Full Text] [Related]  

  • 17. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L
    J Clin Chem Clin Biochem; 1990 May; 28(5):273-8. PubMed ID: 2380662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased erythrocyte uroporphyrinogen-l-synthetase, delta-aminolevulinic acid dehydratase and protoporphyrin in hemolytic anemias.
    Anderson KE; Sassa S; Peterson CM; Kappas A
    Am J Med; 1977 Sep; 63(3):359-64. PubMed ID: 900140
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of erythrocyte hydroxymethylbilane synthase activity and its application for study of acute intermittent porphyria.
    Lee FY; Hsiao KJ; Tsai YT; Lee SD; Wu SJ; Jeng HS
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1029-35. PubMed ID: 3235962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.